Allergy & Immunology
COPD
More in COPD
Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations
Sep 27, 2024
They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert
Sep 10, 2024
Gregory Downey, MD, explains how rising temperatures are driving respiratory health problems
Jun 27, 2024